Notice Health and Human Services DepartmentFood and Drug Administration May 22, 2026

Protein Efficiency Ratio Rat Bioassay Studies To Demonstrate That a New Infant Formula Supports the Quality Factor of Sufficient Biological Quality of Protein; Guidance for Industry; Availability

The Food and Drug Administration (FDA or we) is announcing the availability of a guidance entitled "Protein Efficiency Ratio (PER) Rat Bioassay Studies to Demonstrate That a New Infant Formula...

Sign up to read the full analysis
Document type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-05-22.

Why this matters to food and beverage teams

This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.

Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.

View original source document

Track this document and its deadlines

Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.

Sign Up Free